Acetylcholinesterase Inhibitors as a Starting Point Towards Improved Alzheimers Disease Therapeutics

The knowledge about the pathogenesis and the development of the neurodegeneration associated with

Keywords: neurodegeneration, amyloid, cholinesterase inhibitors, drug design, molecular modelling

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

3

DOI https://dx.doi.org/10.2174/1381612043383313	Print ISSN 1381-6128
Publisher Name Bentham Science Publisher	Online ISSN 1873-4286

Current Pharmaceutical Design